Antibodies are critical reagents used in several biodetection platforms for
the identification of biological agents. Recent advances in phage display
technology allow isolation of high affinity recombinant antibody fragments
(Fabs) that may bind unique epitopes of biological threat agents. The versa
tility of the selection process lends itself to efficient screening methodo
logies and can increase the number of antigen binding clones that can be is
olated. Pilot scale biomanufacturing can then be used for the economical pr
oduction of these immunoglobulin reagents in bacterial fermentation systems
, and expression vectors with hexahistidine tags can be used to simplify do
wnstream purification. One such Fab reagent directed against botulinum neur
otoxin A/B has been shown to be sensitive in a variety of assay formats inc
luding surface plasmon resonance (SPR), flow cytometry, enzyme linked immun
osorbent assay (ELISA), and hand-held immunochromatographic assay. Recombin
ant antibodies can provide another source of high quality detection reagent
s in our arsenal to identify or detect pathogens in environmental samples.
(C) 2000 Elsevier Science S.A. All rights reserved.